Johns Hopkins Researchers Awarded $400K American Cancer Society/Pfizer Grant to Address Disparities in Gynecological Cancer Care
Anne Rositch, PhD, an associate professor in the department of epidemiology at the Johns Hopkins Bloomberg School of Public Health, and her co-PI Anna Beavis, MD, MPH, from the Johns Hopkins University School of Medicine, received a $400,000, two-year grant from the American Cancer Society and Pfizer to address widespread race-related barriers and disparities in gynecological cancer care.
Although cancer affects everyone, Black Americans bear a disproportionate burden of many cancer types and have worse outcomes. Both Black men and women experience persistent racial disparities including the highest death rate of any racial/ethnic group in the United States.
The grant, awarded under the “Addressing Racial Disparities in Cancer Care Competitive Grant Program”, will enable the Hopkins team to develop a scalable and ultimately sustainable way to identify and address the social determinants of health that contribute to these concerns.
Rositch is an applied epidemiologist, concentrating on cancer in women and global cancer disparities. Her research has focuses on cervical and other female cancers in HIV-positive individuals, aging women, and in low-resource settings. It has spanned the translational spectrum from epidemiological studies to understand the natural history of the disease, to studying the effectiveness and implementation of cancer prevention in low-resource settings in the United States and globally.